LoadingHLIO
Chenanda Cary reported Grant or award in HELIOS TECHNOLOGIES, INC.: 601 units of Restricted Stock Units (derivative), dated 2026-09-25. The full Form 4 contains 1 transaction entry.
HLIO
Schuetz Alexander reported Grant or award in HELIOS TECHNOLOGIES, INC.: 601 units of Restricted Stock Units (derivative), dated 2026-09-25. The full Form 4 contains 1 transaction entry.
SCHL
Hukkanen Paul reported Tax/exercise withholding in SCHOLASTIC CORP: 434 units of Common Stock, dated 2026-09-28. The full Form 4 contains 1 transaction entry.
HLIO
Sacchi Diana reported Grant or award in HELIOS TECHNOLOGIES, INC.: 638 units of Restricted Stock Units (derivative), dated 2026-09-25. The full Form 4 contains 1 transaction entry.
SCHL
Quinton Sasha reported Tax/exercise withholding in SCHOLASTIC CORP: 1254 units of Common Stock, dated 2026-09-28. The full Form 4 contains 1 transaction entry.
MNY
Leung Ka Yip Danny reported Grant or award in MoneyHero Ltd: 10072 units of Class A Ordinary Shares, dated 2026-09-25. The full Form 4 contains 1 transaction entry.
SCHL
Lick Chris reported Tax/exercise withholding in SCHOLASTIC CORP: 147 units of Common Stock, dated 2026-09-28. The full Form 4 contains 1 transaction entry.
BJ
Werner William C. reported Tax/exercise withholding in BJ's Wholesale Club Holdings, Inc.: 10007 units of Common Stock, dated 2026-09-27. The full Form 4 contains 1 transaction entry.
CPS
Boddy Matthew W. reported Grant or award in Cooper-Standard Holdings Inc.: 4473 units of Restricted Stock Units (derivative), dated 2026-09-28. The full Form 4 contains 1 transaction entry.
TMO
JOHNSON JENNIFER M reported Grant or award in THERMO FISHER SCIENTIFIC INC.: 46.3 units of Phantom Stock Units (derivative), dated 2026-09-26. The full Form 4 contains 1 transaction entry.
TMO
Keith R. Alexandra reported Grant or award in THERMO FISHER SCIENTIFIC INC.: 46.3 units of Phantom Stock Units (derivative), dated 2026-09-26. The full Form 4 contains 1 transaction entry.
TMO
Lynch Karen S reported Grant or award in THERMO FISHER SCIENTIFIC INC.: 46.3 units of Phantom Stock Units (derivative), dated 2026-09-26. The full Form 4 contains 1 transaction entry.
TMO
SPERLING SCOTT M reported Grant or award in THERMO FISHER SCIENTIFIC INC.: 62.96 units of Phantom Stock Units (derivative), dated 2026-09-26. The full Form 4 contains 1 transaction entry.
TMO
WEISLER DION J reported Grant or award in THERMO FISHER SCIENTIFIC INC.: 55.56 units of Phantom Stock Units (derivative), dated 2026-09-26. The full Form 4 contains 1 transaction entry.
TEM
Schoenherr Thomas Edward reported Sale in Tempus AI, Inc.: 10281 units of Class A Common Stock, dated 2026-09-25. The full Form 4 contains 1 transaction entry.
AIFF
Menawat Arun Swarup reported Grant or award in FIREFLY NEUROSCIENCE, INC.: 126050 units of Deferred Stock Units (derivative), dated 2026-09-25. The full Form 4 contains 1 transaction entry.
AIFF
POSNER BRIAN M reported Grant or award in FIREFLY NEUROSCIENCE, INC.: 84033 units of Deferred Stock Units (derivative), dated 2026-09-25. The full Form 4 contains 1 transaction entry.
AIFF
Vnook Stella reported Grant or award in FIREFLY NEUROSCIENCE, INC.: 84033 units of Deferred Stock Units (derivative), dated 2026-09-25. The full Form 4 contains 1 transaction entry.
Russo Carl reported Grant or award in CALIX, INC: 17603 units of Stock Options (right to buy) (derivative), dated 2026-09-28. The full Form 4 contains 1 transaction entry.
HGBL
DOVE ROSS reported Sale in Heritage Global Inc.: 300000 units of Common Stock, dated 2026-09-25. The full Form 4 contains 1 transaction entry.
IGC
GRIMALDI CLAUDIA reported Gift in IGC Pharma, Inc.: 150000 units of Common Stock, dated 2026-09-25. The full Form 4 contains 1 transaction entry.
PHIO
Plott Ronald Todd reported 17,000 shares of Common Stock, $.0001 par value in Phio Pharmaceuticals Corp. as grants or awards dated 2026-09-28. The Form 4 was disclosed on Sep 29, 2026. These were stock awards, not open-market purchases.
PHIO
Bitterman Robert J reported 400,000 shares of Common Stock, $.0001 par value in Phio Pharmaceuticals Corp. as grants or awards dated 2026-09-28. The Form 4 was disclosed on Sep 29, 2026. These were stock awards, not open-market purchases.
PHIO
Carson Lisa Cabott reported 108,000 shares of Common Stock, $.0001 par value in Phio Pharmaceuticals Corp. as grants or awards dated 2026-09-28. The Form 4 was disclosed on Sep 29, 2026. These were stock awards, not open-market purchases.
AlphaYou
